Metabolomics can distinguish ME/CFS patients from controls and identifies potentially important changed metabolites specific to ME/CFS, which is not found in Multiple Sclerosis patients

Dr Tiffany Lodge

Metabolic profiling in Healthy Controls,

ME/CFS and Multiple Sclerosis

James WL Strong

Metabolic profiling in Healthy Controls &

ME/CFS 

Professor James McCullagh

Analytical Chemistry

Director of the Mass Spectrometry Research Unit

Chemistry Department, University of Oxford